EUVIMEDEUVIMED entdecken
Mixed-Methods-StudieOpen Access

A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study

Frederic Ehrler, Liliane Gschwind, Hamdi Hagberg, Philippe Meyer, Katherine Blondon

JMIR Cardio · 2025

DOI: 10.2196/50693 ↗

Kurz gefasst

Mixed-Methods-Studie in der Zeitschrift JMIR Cardio, 2025. Verfasst von Frederic Ehrler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Information Systems Directorate, University Hospital of Geneva, Geneva, Switzerland. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Mobile Applications, Medication Adherence. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Medication nonadherence remains a significant challenge in the management of chronic conditions, often leading to suboptimal treatment outcomes and increased health care costs. Innovative interventions that address the underlying factors contributing to nonadherence are needed. Gamified mobile apps have shown promise in promoting behavior change and engagement.

Objective

This pilot study aimed to evaluate the efficacy and usability of a gamified mobile app that used a narrative storytelling approach to enhance medication adherence among patients following acute coronary syndrome (ACS). The study aimed to assess changes in participants’ beliefs about medication and self-reported adherence before and after the intervention. Additionally, user feedback regarding the narrative component of the app was gathered.

Methods

Overall, 18 patients who recently experienced ACS were recruited for a 1-month intervention using the gamified app. Participants’ beliefs about medication and self-reported adherence were assessed using standardized scales pre- and postintervention. The app’s usability was also evaluated through a postintervention questionnaire. Statistical analyses were performed to determine the significance of changes in belief and adherence scores.

Results

Although 33% (6/18) of the participants did not use the intervention more than once, the remaining 12 remained engaged during the 30 days of the study. The results did not indicate a significant improvement in participants’ beliefs about medication following the intervention. However, self-reported adherence significantly improved ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Coronary SyndromeMobile ApplicationsMedication AdherenceHumansPilot ProjectsMaleFemaleMiddle AgedAgedSurveys and QuestionnairesSelf Report

Stichwörter der Autor:innen

acute coronary syndromebeliefs about medicationgamified appmedication adherencenarrationpilot studyself-reported adherencestorytelling componentusability evaluation

Autor:innen und Institutionen

  • Information Systems Directorate, University Hospital of Geneva, Geneva, Switzerland.
  • Department of Pharmacy, University Hospital of Geneva, Geneva, Switzerland.
  • Service of Cardiology, University Hospital of Geneva, Geneva, Switzerland.
  • Medicine Faculty, University of Geneva, Geneva, Switzerland.
  • Medical Directorate, University Hospital of Geneva, Geneva, Switzerland.

Zitieren

APA

Ehrler, F., Gschwind, L., Hagberg, H., Meyer, P., & Blondon, K. (2025). A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study. JMIR Cardio. https://doi.org/10.2196/50693

Vancouver

Ehrler F, Gschwind L, Hagberg H, Meyer P, Blondon K. A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study. JMIR Cardio. 2025. doi:10.2196/50693

BibTeX
@article{Ehrler2025,
  author = {Ehrler, Frederic and Gschwind, Liliane and Hagberg, Hamdi and Meyer, Philippe and Blondon, Katherine},
  title = {A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study},
  journal = {JMIR Cardio},
  year = {2025},
  doi = {10.2196/50693}
}
Kostenlos starten →